Matthews, Ivan (1), Smith, Fang Gao (2), Aarons, Leon (1) Pharmacokinetics of a single bolus of propofol in Chinese children of different ages
|
Friberg, Lena E.(1), An M. Vermeulen(2), Mats O. Karlsson(1) A mechanism-based pharmacokinetic-pharmacodynamic model of the time-course of prolactin following antipsychotic drug treatment
|
Miller, Raymond , Howard Bockbrader, Sunny Chapel. Comparision of Pregabalin and Gabapentin Pharmacodynamics in Patients with Refractory Partial Seizures.
|
Marchand, M. (1), O. Petricoul (1), E. Fuseau (1), D. Bentley (2), D. Critchley (2) Extrapolation from preclinical PKPD data to clinical response, Application to a new antiepileptic medication (drug X)
|
Al Za’abi MA (1), Xiaonian X (2), Donovan T (3), Charles BG (1) Use of Routine Data for Determination of the Population Pharmacokinetics and Enteral Bioavailability of Phenytoin in Neonates and Infants with Seizures
|
Boström, Emma, Ulrika S. H. Simonsson and Margareta Hammarlund-Udenaes In vivo blood-brain barrier transport of oxycodone in the rat – active influx and implications for PK/PD
|
Lehr, T. (1), A. Staab (2), C. Tillmann (2), D. Trommeshauser (2), A. Raschig (2), H.G. Schaefer (2), C. Kloft (1,3) Efficacy modelling of NS2330 in mild Alzheimer’s disease patients
|
Lehr, T.(1), A. Staab (2), C. Tillmann (2), D.Trommeshauser (2), A. Raschig(2), H.G. Schaefer (2), C. Kloft (1,3) Population pharmacokinetics of NS2330 and its major metabolite in Alzheimer’s disease patients
|
Valle M, Grasa E, Yritia M, Romero S,, Barbanoj MJ. Population Pharmacokinetic-Pharmacodynamic modelling of olanzapine effects on the electroencephalogram in healthy volunteers.
|
Ortega, Ignacio , An Vermeulen, Vladimir Piotrovsky Concentration-response analysis of antipsychotic drug effects using an indirect response model
|
Marshall, Scott1, Mike K Smith1, Eugene Cox2,3 and Jaap Mandema2,4 Application of PK/PD modelling in the development eletriptan DR for the treatment of acute migraine and prevention of headache recurrence.
|
Hussein, Ziad(1), Brigitte Lacroix(2), Maria-Laura Sargentini-Maier(2) Population pharmacokinetics of the new antiepileptic drug brivaracetam
|